CD38 and acute myeloid leukemia: AML is typically a stem cell-driven disease, and the existence of leukemia stem cells (LSCs) was first identified (CD34 + CD38-) by JE Dick in 1994; these cells extremely promote AML progression, chemo-resistance and recurrence [3,4].